SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is attracting intense trader interest following an oversubscribed private placement announcement intended to fund its FB102 clinical trials. The community remains sharply divided, with some investors betting on a continued momentum-driven squeeze while others warn of potential dilution and expect a rapid retracement.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is seeing significant volatility and intense community discussion following a partnership announcement with Nvidia to integrate battery technology into AI data center infrastructure. Investors are debating whether this catalyst and growing grid demand can overcome recent insider selling and price consolidation, as the community remains sharply divided between those calling it a high-upside accumulation play and those wary of current margin and profitability challenges.

Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.

Amarin Corp - ADR

Investors are closely monitoring the upcoming Supreme Court oral arguments and Q1 financial results, both scheduled for late April, which serve as primary catalysts for potential stock movement. Community sentiment remains deeply divided between long-term holders hopeful for a favorable legal outcome or strategic buyout and frustrated participants critical of management's perceived lack of transparency and shareholder value creation.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis Inc is trending following reports that the cancer-diagnostics company is exploring potential sale options, drawing interest from Merck and other undisclosed suitors. The community is actively discussing the strategic value of Personalis' platform and the potential for a competitive bidding process, as investors weigh the implications of existing institutional partnerships.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors weigh persistent leadership frustration against the company's recent FDA label expansion for Ibrance. While some community members remain optimistic about potential pipeline breakthroughs, sentiment is heavily weighed down by ongoing pipeline disappointments and broader concerns regarding the stock's long-term performance.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is trending amidst a backdrop of heavy community speculation regarding price volatility and its future correlation with major crypto assets. Investors are actively debating the coin's long-term utility while expressing polarized sentiment over its recent market performance.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Abbott Laboratories

Abbott Laboratories is trending as investors digest a second-quarter beat and raised full-year earnings guidance, driving significant bullish sentiment and talk of a potential sector rotation into defensive healthcare stocks. While some community members remain cautious about valuation and past acquisition performance, many are actively discussing potential re-rating opportunities and the company's long-term strength as a Dividend Aristocrat.

TOSHI

TOSHI is drawing significant attention as investors speculate on potential ecosystem developments, including AI integration and partnership news, leading many to view current levels as a major accumulation zone. The community is actively debating the project's utility and long-term potential as the "face of Base," with many bulls anticipating a significant move once volume returns and broader market conditions improve.

Wolfspeed, Inc. is an innovator of wide bandgap semiconductors, focused on silicon carbide and gallium nitride (GaN) materials and devices for power and radiofrequency (RF) applications. Its product families include silicon carbide and GaN materials, power devices and RF devices, and its products are targeted for various applications such as electric vehicles, fast charging, 5G, renewable energy and storage, and aerospace and defense. The company was founded by Calvin H. Carter Jr., John W. Palmour, F. Neal Hunter, Eric Hunter, and John Edmond in 1987 and is headquartered in Durham, NC.

Wolfspeed Inc - Ordinary Shares (New)

Wolfspeed Inc

Wolfspeed is experiencing significant volatility driven by intense debate over its high short interest and speculative short squeeze potential, while investors remain divided on the company's long-term viability amid ongoing production concerns at its Siler City facility. Community sentiment is deeply polarized, with bulls pointing to the company's role as a critical U.S. silicon carbide provider as a catalyst for a rebound, while bears emphasize cash burn, share dilution, and consistent underperformance as reasons to avoid the stock.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is generating significant debate as investors weigh its potential as a specialized AI power infrastructure provider against the broader volatility of the residential solar market. The community is sharply divided, with bulls pointing to the company's emerging solid-state transformer technology as a long-term growth catalyst, while bears emphasize historical volatility, high short interest, and sensitivity to policy risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Northeast Bancorp (NASDAQ:NBN) Price Target Raised to $128.00

Keefe, Bruyette & Woods lifted their target price on Northeast Bancorp from $120.00 to $128.00 and gave the company a "market perform" rating in a research note on Wednesday...

Northeast Bancorp (NASDAQ:NBN) Sets New 1-Year High  - Still a Buy?

Northeast Bancorp (NASDAQ:NBN) Reaches New 1-Year High - Still a Buy...

Northeast Bancorp Q3 Earnings Call Highlights

Northeast Bancorp (NASDAQ:NBN) executives highlighted what they described as a record-setting third quarter of fiscal 2026, driven by strong loan originations, higher net interest income and a...

Northeast Bank Q3 2026 Earnings Call: Complete Transcript

Northeast Bancorp (NASDAQ:NBN) Shares Up 6.3% After Strong Earnings

Northeast Bancorp (NASDAQ:NBN) Trading 6.3% Higher After Earnings Beat...

Northeast Bancorp (NASDAQ:NBN) Announces Earnings Results, Beats Expectations By $0.50 EPS

Northeast Bancorp (NASDAQ:NBN - Get Free Report) announced its quarterly earnings results on Monday. The financial services provider reported $3.53 earnings per share (EPS) for the quarter, topping...

Northeast Bancorp (NBN) Expected to Announce Quarterly Earnings on Monday

Northeast Bancorp (NASDAQ:NBN) will be releasing its Q3 2026 earnings before the market opens on Monday, April 27. (View Earnings Report at...

Northeast Bancorp (NASDAQ:NBN) Sets New 1-Year High - Here's What Happened

Northeast Bancorp (NASDAQ:NBN) Sets New 52-Week High - Still a Buy...

Northeast Bancorp (NASDAQ:NBN) Sees Large Increase in Short Interest

Northeast Bancorp (NASDAQ:NBN - Get Free Report) was the recipient of a large growth in short interest in March. As of March 13th, there was short interest totaling 433,815 shares, a growth of 25.0% from the February 26th total of 346,952 shares. Currently, 6.2% of the company's stock are sold...

Northeast Bancorp (NASDAQ:NBN) Now Covered by Analysts at Piper Sandler

Piper Sandler assumed coverage on shares of Northeast Bancorp in a report on Monday. They set an "overweight" rating and a $133.00 price target for the company...

Northeast Bank (Maine) engages in offering personal and business banking services. The company provides commercial loans nationally secured by all types of real estate, equipment or other business assets, including government guaranteed loans. It also provides a full range of business banking services, from banking accounts to financing options to cash management. The company was founded in 1872 and is headquartered in Portland, ME.

Northeast Bank

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$3.40	--	--	N/A
Q3 '26	$2.99	$3.53	17.86%	BEAT
Q2 '26	$2.44	$2.47	1.02%	BEAT
Q1 '26	$2.68	$2.67	-0.37%	MISSED
Q4 '25	$2.57	$3.00	16.73%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

NBNNortheast Bank

Upcoming Earnings: Q4 '26

Historical Earnings

Latest NBN News